Exact Sciences Enters MRD Market With Oncodetect Launch But Faces Competition, Reimbursement Challenges

Analysts Voiced Cautious Optimism About Launch But Pointed Out Lingering Uncertainties

 
• By Shubham Singh
  
The commercial launch of Oncodetect, announced 22 April, came in line with Exact Sciences’ previously communicated timeline for a second-quarter 2025 rollout, but notably without securing Medicare coverage.

More from Oncology

More from Medtech Insight